Income Statement

LEMAITRE VASCULAR INC

LMAT
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY Dec 31, 2013 2013 FY Dec 31, 2012 2012 FY Dec 31, 2011 2011 FY
Revenue
- - - - - - - - 100.87 89.15 78.35 71.10 64.55 56.74 57.69
Cost of Revenue
71.06 68.96 66.44 56.76 53.04 44.75 37.38 31.63 - - - - - - -
Gross Profit
178.54 150.90 127.05 104.90 101.38 84.62 79.85 73.94 70.70 62.94 54.17 48.43 45.12 40.87 40.23
Operating Expenses
110.63 98.65 90.34 78.07 64.96 55.83 58.67 45.73 49.59 46.60 42.65 42.09 40.60 36.63 36.54
Research & Development
14.14 15.65 16.97 13.29 11.80 10.10 9.28 8.20 6.64 6.14 5.48 4.67 5.24 5.09 4.43
Selling, General & Administrative
54.46 46.74 41.05 32.92 27.66 23.70 30.34 27.32 25.95 26.11 22.78 22.09 22.14 20.81 19.38
Other Operating Expenses
- - - - - - - - - - - - - - -
Operating Income
67.91 52.26 36.71 26.83 36.43 28.79 21.18 28.21 21.10 16.34 11.51 6.34 4.52 4.24 3.69
Non-Operating Income
-7.27 -4.62 -2.76 -0.66 2.14 1.43 -0.50 -0.24 0.00 0.09 0.09 0.02 0.19 0.25 -0.06
Interest Income
13.09 4.95 3.08 0.99 0.20 0.21 0.70 0.63 0.18 0.08 0.01 0.00 0.00 0.08 0.01
Interest Expense
5.18 0.21 0.00 0.00 2.22 1.31 - 0.00 0.02 0.01 - 0.01 0.01 0.00 -
Other Non-Op Income / Expense
-0.64 -0.13 -0.31 -0.33 - - - - - - - - - 0.01 -
Income Before Tax
75.18 56.88 39.48 27.49 34.29 27.36 21.68 28.44 21.11 16.24 11.42 6.32 4.33 3.99 3.75
Income Tax Expense
17.45 12.84 9.37 6.85 7.38 6.14 3.75 -1.10 3.93 5.65 3.67 2.41 1.13 1.42 1.61
Non-Controlling Interest
- - - - - - - - - - - - - - -
Net Income
57.73 44.04 30.11 20.64 26.91 21.22 -17.93 -24.04 17.18 10.59 7.76 3.92 3.20 2.57 2.14
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY Dec 31, 2013 2013 FY Dec 31, 2012 2012 FY Dec 31, 2011 2011 FY
Depreciation & Amortization
- - - - - - - - - - - - - - -
EBITDA
78.33 61.93 46.23 36.26 47.50 37.18 26.60 32.53 25.16 19.93 14.91 9.67 7.31 6.47 5.73
Earnings Per Share (Basic)
2.55 1.96 1.36 0.94 1.27 1.05 0.91 1.18 0.91 0.57 0.44 0.24 0.21 0.17 0.14
Diluted EPS
2.52 1.93 1.34 0.93 1.25 1.04 0.88 1.13 0.86 0.55 0.42 0.23 0.20 0.16 0.13
Weighted Average Shares
22.64 22.45 22.22 21.98 21.16 20.25 19.81 19.43 18.96 18.49 17.76 16.61 15.32 15.19 15.46
Diluted Weighted Avg Shares
22.93 22.78 22.42 22.17 21.48 20.48 20.33 20.24 20.03 19.24 18.32 17.01 15.76 15.64 15.99
Comprehensive Income
61.51 42.48 31.51 18.04 25.00 23.70 17.83 21.33 19.47 10.06 6.07 1.80 3.38 2.74 -